Prostate Cancer With Normal Prostate Tissue Array, Including TNM, Pathology Grade, Gleason Grade And Gleason Score, 24cases/48 Cores, Replacing PR482|ヒト組織アレイ
掲載日情報:2016/03/01 現在Webページ番号:179148
US Biomax社は、組織アレイを提供しているメーカーです。
US Biomax社のヒト組織アレイ(Prostate Cancer With Normal Prostate Tissue Array, Including TNM, Pathology Grade, Gleason Grade And Gleason Score, 24cases/48 Cores, Replacing PR482)をご紹介します。
※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIVおよびHepatitis Bが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。
追加しました。
ヒト組織アレイの価格
[在庫・価格 :2025年04月29日 20時35分現在]
詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prostate cancer with normal prostate tissue array, including TNM, pathology grade, Gleason grade and gleason score, 24・・・ |
|
0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
[在庫・価格 :2025年04月29日 20時35分現在]
Prostate cancer with normal prostate tissue array, including TNM, pathology grade, Gleason grade and gleason score, 24・・・
文献数: 0
- 商品コード:PR482a
- メーカー:USB
- 包装:1slide
- 価格:¥51,000
- 在庫:無(未発注)
- 納期:2~3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等:
説明文 | |||
---|---|---|---|
法規制等 | |||
保存条件 | 室温,暗所保存 | 法規備考 | |
掲載カタログ |
|
||
製品記事 | TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド |
||
関連記事 | TissueArray.Com社 パラフィン組織スライド/組織アレイの仕様変更につきまして |
追加しました。
ヒト組織アレイの特長
Microarray Panel: | Prostate adenocarcinoma and normal prostate tissue microarray, containing 20 cases of prostate adenocarcinoma and 4 normal prostate tissues, duplicated cores per case | |
---|---|---|
Cores: | 48 | |
Cases: | 24 | |
Layout: | 8 cols × 6 rows | |
Core Diameter: | 1.5 mm | |
Thickness: | 5 µm | |
Applications: | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. |
|
Notes: | 1. TMA slides were sectioned and stored at 4C, may not be fresh cut. Please request fresh cut if experiment involves phosphor-specific antibodies, FISH or ISH, etc., minimal 3 slides be purchased of each TMA apllies to cover the cost of trimming for the fresh sectioning. 2. Most of TMA slides were not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), but it is still recommended 30 min. of baking at 60C before putting into xylene for de-paraffinization procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H and E: Hematoxylin and Eosin stained tissue array slide.
追加しました。
ヒト組織アレイの仕様表
Pos | No. | Sex | Age | Organ | Pathology diagnosis | Grade | Gleason Grade | Gleason Score | TNM | Type † |
---|---|---|---|---|---|---|---|---|---|---|
A1 | 1 | M | 72 | Prostate | Adenocarcinoma | 1 | 3 | 2+3 | T2NxM0 | Malignant |
A2 | 2 | M | 72 | Prostate | Adenocarcinoma | 1 | 3 | 2+4 | T2NxM0 | Malignant |
A3 | 3 | M | 69 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T1bNxM0 | Malignant |
A4 | 4 | M | 69 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T1bNxM0 | Malignant |
A5 | 5 | M | 74 | Prostate | Adenocarcinoma | 2 | 3 | 3+4 | T2bNxM0 | Malignant |
A6 | 6 | M | 74 | Prostate | Adenocarcinoma | 2 | 3 | 3+4 | T2bNxM0 | Malignant |
A7 | 7 | M | 63 | Prostate | Adenocarcinoma | 2 | 3 | 3+3 | T2NxM0 | Malignant |
A8 | 8 | M | 63 | Prostate | Adenocarcinoma | 2 | 3 | 3+3 | T2NxM0 | Malignant |
B1 | 9 | M | 75 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T3NxM0 | Malignant |
B2 | 10 | M | 75 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T3NxM0 | Malignant |
B3 | 11 | M | 61 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
B4 | 12 | M | 61 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
B5 | 13 | M | 73 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
B6 | 14 | M | 73 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
B7 | 15 | M | 20 | Prostate | Adenocarcinoma | 2 | 3 | 3+4 | T2NxM0 | Malignant |
B8 | 16 | M | 20 | Prostate | Adenocarcinoma | 2 | 3 | 3+4 | T2NxM0 | Malignant |
C1 | 17 | M | 73 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
C2 | 18 | M | 73 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
C3 | 19 | M | 70 | Prostate | Adenocarcinoma | 3 | 5 | 5+5 | T2NxM0 | Malignant |
C4 | 20 | M | 70 | Prostate | Adenocarcinoma | 3 | 5 | 5+5 | T2NxM0 | Malignant |
C5 | 21 | M | 65 | Prostate | Adenocarcinoma | 1 | 2 | 2+3 | T2NxM0 | Malignant |
C6 | 22 | M | 65 | Prostate | Adenocarcinoma | 1 | 2 | 2+3 | T2NxM0 | Malignant |
C7 | 23 | M | 64 | Prostate | Adenocarcinoma | 2 | 3 | 3+4 | T4NxM0 | Malignant |
C8 | 24 | M | 64 | Prostate | Adenocarcinoma | 2 | 3 | 3+4 | T4NxM0 | Malignant |
D1 | 25 | M | 62 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
D2 | 26 | M | 62 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
D3 | 27 | M | 73 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T3NxMo | Malignant |
D4 | 28 | M | 73 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T3NxMo | Malignant |
D5 | 29 | M | 64 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
D6 | 30 | M | 64 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
D7 | 31 | M | 65 | Prostate | Adenocarcinoma | 2 | 3 | 3+3 | T2NxM0 | Malignant |
D8 | 32 | M | 65 | Prostate | Adenocarcinoma | 2 | 3 | 3+3 | T2NxM0 | Malignant |
E1 | 33 | M | 82 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
E2 | 34 | M | 82 | Prostate | Adenocarcinoma | 3 | 4 | 4+4 | T2NxM0 | Malignant |
E3 | 35 | M | 60 | Prostate | Adenocarcinoma | 3 | 4 | 4+5 | T2NxM0 | Malignant |
E4 | 36 | M | 60 | Prostate | Adenocarcinoma | 3 | 4 | 4+5 | T2NxM0 | Malignant |
E5 | 37 | M | 26 | Prostate | Adenocarcinoma | 3 | 4 | 4+5 | T2NxM0 | Malignant |
E6 | 38 | M | 26 | Prostate | Adenocarcinoma | 3 | 4 | 4+5 | T2NxM0 | Malignant |
E7 | 39 | M | 62 | Prostate | Adenocarcinoma | 3 | 5 | 5+5 | T2NxM0 | Malignant |
E8 | 40 | M | 62 | Prostate | Adenocarcinoma | 3 | 5 | 5+5 | T2NxM0 | Malignant |
F1 | 41 | M | 35 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F2 | 42 | M | 35 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F3 | 43 | M | 35 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F4 | 44 | M | 35 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F5 | 45 | M | 40 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F6 | 46 | M | 40 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F7 | 47 | M | 30 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
F8 | 48 | M | 30 | Prostate | Normal prostatic tissue | – | – | – | – | Normal |
– | – | M | 42 | Adrenal gland | Pheochromocytoma (tissue marker) | – | Malignant |
*For precise diagnosis, refer to pathology description.
追加しました。
ヒト組織アレイのFAQ
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。